12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Tuesday's pre-market session, health care stocks showed significant movement. Stoke Therapeutics and OpGen were among the top gainers, with stocks soaring by 80.2% and 77.6% respectively, following their Q4 earnings reports. ABVC BioPharma, Mesoblast, Praxis Precision Medicine, and Sutro Biopharma also saw notable increases. On the downside, NeuBase Therapeutics led the losers, dropping by 55%, followed by Tivic Health Systems, bluebird bio, BioLine Rx, iSpecimen, and IMAC Holdings, all experiencing declines post their Q4 earnings announcements.
March 26, 2024 | 1:05 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
bluebird bio's shares fell 12.51% to $1.19, with a market cap of $229.3 million, after their Q4 earnings were released.
The decline in bluebird bio's stock price post-Q4 earnings suggests the market's negative response to their financial performance.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 85
NEGATIVE IMPACT
NeuBase Therapeutics' stock plummeted by 55% to $0.45, with a market cap of $1.6 million, following their pre-market session performance.
The sharp decline in NeuBase Therapeutics' stock price could be attributed to negative investor reaction to their recent performance or earnings report.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 90
POSITIVE IMPACT
OpGen shares increased by 77.6% to $0.84, with a market cap of $8.4 million, likely driven by their recent Q4 earnings announcement.
OpGen's stock price jump is likely a result of investor optimism following their Q4 earnings report, suggesting a positive financial performance.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 85
POSITIVE IMPACT
Stoke Therapeutics' stock surged 80.2% to $11.71 in pre-market trading following their Q4 earnings report, with a market cap of $522.8 million.
The significant surge in Stoke Therapeutics' stock price is directly attributed to the positive reception of their Q4 earnings report, indicating strong investor confidence.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 90